Connect your AI

Sera Prognostics SERA Change in receivables

Change in receivables at other companies

Cabot CorporationCBT

-$64M-256%

Ryan Specialty HoldingsRYAN

$77.8M+355%

Federated HermesFHI

$4.62M-57.8%

10x Genomics, Inc.TXG

-$18.13M—

Sharplink, Inc. SBET

-$273K-500%

US Physical TherapyUSPH

$2.6M+435%

Other financials

Income statement

Revenue$14.0K-63.2%

Operating income-$9.4M-1.2%

Net income-$8.4M-2.6%

EPS (diluted)-$0.17+15.0%

Balance sheet

Cash & equivalents$4.2M-20.2%

Total debt$2.5M+286%

Total equity$67.6M-28.7%

Total assets$93.5M-20.8%

Cash flow

Operating cash flow-$8.8M-16.2%

CapEx$8.0K+167%

Free cash flow-$8.8M-16.2%

Valuation

Market cap$71.27M+5.0%

Enterprise value$69.6M+9.6%

P/S1,250.3×+622×

Profitability

Operating margin-64,235.1%-8,092,342pp

Net margin-56,386%+1,586,573pp

FCF margin-48,377.2%-673,104pp

Returns & leverage

Return on equity-39.6%-1.6pp

Debt / equity0×0.0×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherReceivables.

The official record: Sera Prognostics’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sera Prognostics's change in receivables?: Sera Prognostics (SERA) reported change in receivables of -$19K in Q2 2025.
What does change in receivables mean?: Change in total receivables including trade and non-trade receivables.